Where are you on your gen AI journey? This guide by CNET's experts will point you in the right direction. Jon Skillings is an ...

Successful economic development doesn't often glide along a smooth path. And it is far from a rapid process. Those were among the sentiments gleaned from a Wednesday presentation by Dr. John Deskins, ...

Discover the top 3 undervalued Diversified Consumer Services stocks for Wednesday, April 23 based on AAII’s Stock Grades.

As the diabetes and weight loss market booms, more collaboration between pharma and medtech could help patients get the most ...

Eligible participants were aged 50 and over, had a diagnosis of tT2D, and no prior history of dementia or use of ...

SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.

A large population-based study found that GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is), two classes of ...

A new study links two widely prescribed diabetes drugs to a 33–43% lower ... while promoting mitochondrial function. Both drug classes are associated with improved vascular health and beneficial ...

Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...

2025 — Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, diabetes experts ... Mar. 27, 2025 — A research team has ...

SGLT-2 inhibitor use vs DPP-4 inhibitor use was associated with lower incidence of epilepsy among patients with type 2 diabetes.

taking your medications – it is a lot to learn and balance. Dining with Diabetes may be one way of helping with some of these components. This class series will help you learn about diabetes and ...